Overview
Lobbying Costs
1,000,000€ - 1,249,999€
Financial year: Apr 2023 - Mar 2024
Lobbyists (Full time equivalent)
1.75 Fte (5)
Lobbyists with EP accreditation
4
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
Takeda Pharmaceuticals International AG (Takeda)
EU Transparency Register
815176718826-78 First registered on 17 Sep 2015
Goals / Remit
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 243-year history in Japan. Established by our founding spirit and integral to every part of our business, Takeda-ism and our priorities (Patient, Trust, Reputation, Business) guide us in our efforts to achieve our Vision 2025.
Takeda is headquartered in Tokyo, Japan and focuses its R&D on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.
We aspire to bring our leadership in translating science into life-changing medicines to the next level, in our core focus areas: oncology, gastroentero (...)Main EU files targeted
We follow EU initiatives, policies and legislative files related to our Pharmaceuticals and Vaccines businesses. This includes topics such as R&D and clinical trials, data protection, relevant pharmaceutical legislation and initiatives, medical devices, trade & IP, environment.
Address
Head Office
Thurgauerstrasse 130Glattpark-Opfikon
Zurich 8152
SWITZERLANDEU Office
Square de Meeûs 37
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 50% 2 25% 3 Lobbyists (Full time equivalent)
1.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
4 accreditations were / are live (in bold) for the selected state of 22 Dec 2024
Name Start date End Date Ricardo Werner Marek 09 Dec 2024 09 Dec 2025 Atakan Yesil 07 Nov 2024 07 Nov 2025 Toon DIGNEFFE 16 Oct 2024 16 Oct 2025 Noel Minnis 16 Oct 2024 16 Oct 2025 Toon DIGNEFFE 05 Oct 2019 03 Oct 2020 Mr Richard CORLISS 05 Oct 2019 03 Oct 2020 Complementary Information
Staff who only occasionally contribute to activities covered by the register, or who do not perform significant activities other than normal participation by organisation representatives in EFPIA, EUCOPE and similar working groups, are excluded from the above calculation.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Takeda is a member of European Federation of Pharmaceutical Industries and Associations (EFPIA)
Takeda is member of EUCOPE (European Confederation of Pharmaceutical Enterpreneurs)
Takeda is also member of EuropaBio, PPTA Europe, Japanese Business Council Europe and Friends of EuropeMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Apr 2023 - Mar 2024
Lobbying costs for closed financial year
1,000,000€ - 1,249,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount rpp group 25,000€ - 49,999€ fipra international 100,000€ - 199,999€ acumen public affairs 25,000€ - 49,999€ Intermediaries for current year
Name fipra international acumen public affairs Closed year Costs
1,000,000€ - 1,249,999€
Other financial info
Declaration as per guidelines from the EU Transparency Register. Source for EU funding as per Financial Transparency Register
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Mainly via participation at events organised by Trade Associations.
Other activities
None declared
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 20 Jan 2023 Location Brussels Subject EU-US Mutual Recognition Agreement on Pharmaceutical Good Manufacturing Practices Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 14 Sep 2017 Location Brussels, Belgium Subject eHealth Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)